▲ +8.70% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Akumin in the last 3 months. The average price target is C$4.25, with a high forecast of C$5.25 and a low forecast of C$3.25. The average price target represents a 8.70% upside from the last price of C$3.91.
The current consensus among 2 contributing investment analysts is to buy stock in Akumin. This rating has held steady since January 2021, when it changed from a Hold consensus rating.
Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.